In the meta-analysis of GWAS, we identified two novel loci associated with prostate cancer, rs58262369 at 14q23.2 (ESR2; Fig. 4a) and rs12791447 at 11p15.4 (PPFIBP2; Fig. 4b). Here, ESR2 is linked to prostate carcinoma.